Treace Medical Concepts
TMCI
125 hedge funds and large institutions have $226M invested in Treace Medical Concepts in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 30 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 40
0.53% more ownership
Funds ownership: 60.58% → 61.11% (+0.53%)
9% less funds holding
Funds holding: 138 → 125 (-13)
28% less capital invested
Capital invested by funds: $315M → $226M (-$89.2M)
37% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 30
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.99M |
| 2 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
+$3.67M |
| 3 |
GS
Gagnon Securities
New York
|
+$3.28M |
| 4 |
First Eagle Investment Management
New York
|
+$2.67M |
| 5 |
GA
Gagnon Advisors
New York
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$3.95M |
| 2 |
Morgan Stanley
New York
|
-$3.34M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.34M |
| 4 |
LCG
Lisanti Capital Growth
New York
|
-$2.12M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.82M |
TMCI Hedge Fund Activity: Q2 2025 in Review
125 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q2 2025, worth a combined $226M — down 28% from $315M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of TMCI and 19 opened new positions — a net loss of 11 holders — while 40 trimmed existing stakes and 49 added.
The largest buyer was Millennium Management, adding an estimated $6.99M. The largest seller was CIBC Private Wealth Group, cutting an estimated $3.95M.
- 125 institutional investors held Treace Medical Concepts (TMCI) as of Q2 2025, down from 138 in Q1 2025.
- Funds reported $226M of Treace Medical Concepts stock for Q2 2025, down 28% quarter-over-quarter.
- 19 funds opened new Treace Medical Concepts positions in Q2 2025 and 30 closed out, a net change of -11 holders.
- The largest Treace Medical Concepts buyer in Q2 2025 was Millennium Management, an estimated $6.99M added.
- The largest Treace Medical Concepts seller in Q2 2025 was CIBC Private Wealth Group, an estimated $3.95M sold.
Based on aggregated 13F filings for Q2 2025.